I-Corps™ at NIH and Fast-Track

TMT-Rx has been selected by the National Institutes of Health for two prestigious programs, the I-Corps™ at NIH program, and the NIH Fast-Track Small Business Innovation Research program.

I-Corps™ at NIH provides provides funding, mentoring, and networking opportunities to help commercialize promising biomedical technology. During the course of the 8.5 week, hands-on program, TMT-Rx will work with commercialization experts to focus on further development of it’s business and commercialization plan efforts.

The NIH Fast-Track program, and award of over $1.3 million, provides expedited award decisions and funding of SBIR and STTR Phase II applications for scientifically meritorious projects that have a high potential for commercialization.